These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9847982)

  • 1. Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy.
    Tchernof A; Calles-Escandon J; Sites CK; Poehlman ET
    Coron Artery Dis; 1998; 9(8):503-11. PubMed ID: 9847982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body fat distribution, the menopause transition, and hormone replacement therapy.
    Tchernof A; Poehlman ET; Després JP
    Diabetes Metab; 2000 Feb; 26(1):12-20. PubMed ID: 10705099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the menopause transition on body fatness and body fat distribution.
    Tchernof A; Poehlman ET
    Obes Res; 1998 May; 6(3):246-54. PubMed ID: 9618130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopause, energy expenditure, and body composition.
    Poehlman ET
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):603-11. PubMed ID: 12190834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical activity and weight gain and fat distribution changes with menopause: current evidence and research issues.
    Astrup A
    Med Sci Sports Exerc; 1999 Nov; 31(11 Suppl):S564-7. PubMed ID: 10593529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women.
    Sites CK; Brochu M; Tchernof A; Poehlman ET
    Metabolism; 2001 Jul; 50(7):835-40. PubMed ID: 11436191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause.
    Haarbo J; Marslew U; Gotfredsen A; Christiansen C
    Metabolism; 1991 Dec; 40(12):1323-6. PubMed ID: 1961129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traversing the menopause: changes in energy expenditure and body composition.
    Poehlman ET; Tchernof A
    Coron Artery Dis; 1998; 9(12):799-803. PubMed ID: 9894924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study.
    Fineberg SE
    Drugs Aging; 2000 Dec; 17(6):453-61. PubMed ID: 11200306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopause-related changes in body fat distribution.
    Toth MJ; Tchernof A; Sites CK; Poehlman ET
    Ann N Y Acad Sci; 2000 May; 904():502-6. PubMed ID: 10865795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships of insulin sensitivity with fatness and fitness and in older men and women.
    Ouyang P; Sung J; Kelemen MD; Hees PS; DeRegis JR; Turner KL; Bacher AC; Stewart KJ
    J Womens Health (Larchmt); 2004 Mar; 13(2):177-85. PubMed ID: 15072732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial.
    Sites CK; L'Hommedieu GD; Toth MJ; Brochu M; Cooper BC; Fairhurst PA
    J Clin Endocrinol Metab; 2005 May; 90(5):2701-7. PubMed ID: 15687338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
    Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding weight gain at menopause.
    Davis SR; Castelo-Branco C; Chedraui P; Lumsden MA; Nappi RE; Shah D; Villaseca P;
    Climacteric; 2012 Oct; 15(5):419-29. PubMed ID: 22978257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous exposure to hormone replacement therapy and confounders in metabolic studies.
    Sites CK; L'Hommedieu GD; Brochu M; Poehlman ET
    Menopause; 2001; 8(4):281-5. PubMed ID: 11449086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of factors involved in fat metabolism with age and the menopause transition.
    Misso ML; Jang C; Adams J; Tran J; Murata Y; Bell R; Boon WC; Simpson ER; Davis SR
    Maturitas; 2005 Jul; 51(3):299-306. PubMed ID: 15978974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study.
    Green JS; Stanforth PR; Rankinen T; Leon AS; Rao Dc Dc; Skinner JS; Bouchard C; Wilmore JH
    Metabolism; 2004 Sep; 53(9):1192-6. PubMed ID: 15334383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
    Gower BA; Nagy TR; Goran MI; Smith A; Kent E
    J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.